420 Investor launched in 2013, just ahead of Colorado legalizing for adult-use. We have moved the service to Seeking Alpha. Historically, we have provided great coverage of the sector with model portfolios, videos and written material to help investors learn about cannabis stocks, and we are excited to be doing it here!Glass House Brands ( GLASF ) is a pretty popular cannabis stock. Based in California, it has performed very well relative to other cannabis stocks over the past several years. I don't include ...

Core Insights - Proactive provides fast, accessible, and actionable business and finance news content to a global investment audience [2] - The company focuses on medium and small-cap markets while also covering blue-chip companies and broader investment stories [3] - Proactive's news team delivers insights across various sectors including biotech, mining, oil and gas, and emerging technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]

Core Insights - The article discusses the launch and evolution of the 420 Investor service, which focuses on cannabis stocks, and its recent move to Seeking Alpha [1] - The analyst expresses a cautious stance on cannabis stocks but highlights Green Thumb Industries (OTCQX:GTBIF) as a favorable investment opportunity [1] Group 1: Company Overview - 420 Investor was established in 2013, coinciding with Colorado's legalization of cannabis for adult use [1] - The service has transitioned to Seeking Alpha, continuing to provide extensive coverage of the cannabis sector [1] - Alan Brochstein, a prominent figure in cannabis investment, has been managing the 420 Investor group and closely monitors 20 cannabis stocks [1] Group 2: Investment Analysis - The analyst downgraded Green Thumb Industries from Hold to Sell when its price was $5.60 in April [1] - The investment group offers various resources, including model portfolios, weekly videos, earnings report previews, and a monthly newsletter [1]

Market Trends & Regulatory Landscape - Cannabis stocks have rallied in recent months due to industry-friendly headlines from Washington [1] - The potential rescheduling of cannabis to Schedule 3 by the DEA is being discussed, possibly initiated by an executive order from President Trump [4][5] - Rescheduling could trigger a domino effect, enabling safe banking and major exchange listings for US cannabis companies [11] - Investors remain cautious due to past unfulfilled promises from politicians regarding cannabis reform [6] Investment Opportunities & Risks - US multi-state operators (MSOs) are generating billions in revenue in states with medical or adult-use cannabis programs [9] - These US companies operate contrary to federal law and are unable to list on major US exchanges or access traditional banking services [9] - Advisor Shares Pure US Cannabis ETF (MSOS) specializes in US MSOs, offering a way to invest in these companies [9] - Top picks include Curaleaf, a multi-state operator with hemp beverage interests, and Trulieve, a dominant force in Florida's medical market [12][13] Comparison with Canadian Companies - Canadian cannabis companies like Aurora, Tilray, and Canopy cannot have THC cannabis business in the US but are listed on major US exchanges [8] - US MSOs present a different investment opportunity compared to Canadian companies [13]

Core Insights - The initial optimism surrounding the legalization of recreational cannabis in Canada in 2018 has significantly diminished, leading to disappointing performance in cannabis equities over the past six years [1][2] Industry Overview - Following the 2018 reforms, Canadian licensed producers sought to list on U.S. exchanges, attracting billions in investments based on expectations of swift legalization across the U.S. [3] - Despite state-level legalization, marijuana remains illegal federally in the U.S., creating a complex regulatory environment and imposing high tax burdens, particularly under IRS Section 280E [4] - Legislative divisions persist regarding marijuana legalization, with recent attempts to impose new restrictions on hemp being removed after industry pushback [5] Company Performance - Major Canadian cannabis companies like Tilray Brands (TLRY) and Canopy Growth Corporation (CGC) have seen their stock values plummet from initial multi-billion-dollar valuations due to declining revenues and ongoing losses [6] - U.S.-based Green Thumb Industries (GTBIF), despite being one of the few cannabis companies still valued over a billion dollars, faces similar structural challenges [6] - Some companies are diversifying their operations; for instance, Tilray is expanding into craft beer and beverage alcohol, while Canopy Growth is focusing on health and wellness brands [7] Market Trends - The AdvisorShares Pure US Cannabis ETF, a benchmark for U.S. marijuana equities, has decreased by 86% over the past five years, indicating a severe downturn in the industry [8] - The potential for U.S. federal reform remains a key catalyst for recovery, as changes in marijuana's legal status could alleviate tax burdens and improve access to banking [9][10] - International markets, particularly in Europe and Australia, are showing growth opportunities, which, combined with potential U.S. policy shifts, could lead to a rebound in the sector [11] Alternative Investment Opportunities - For investors seeking exposure to the cannabis sector without the volatility of pure-play cannabis stocks, companies like Harmony Biosciences (HRMY) and Corbus Pharmaceuticals (CRBP) are developing cannabinoid-based medicines for various medical conditions [13]